NYKODE THERAPEUTICS ASA

0349 OSLO

Finances

Share Ownership

Return on Equity

−27,22 %

Current Ratio

5,43

Debt-to-Equity Ratio

0,16

Key figures (USD)	2022	2021	2020	2019
Revenue	9 029 000	35 766 000	215 695 000	12 446 000
Net Income	−42 743 000	−9 413 000	149 774 000	−95 956 000
Total Assets	221 477 000	265 556 000	230 028 000	292 254 000
Total Equity	157 018 000	194 055 000	178 850 000	268 439 000

Income (USD)	2022	2021	2020	2019
Revenue	9 029 000	35 766 000	215 695 000	12 446 000
Expenditure	62 185 000	46 541 000	37 430 000	111 338 000
Operating Profit	−53 156 000	−10 775 000	178 265 000	−98 892 000
Financial Income	8 637 000	4 133 000	3 815 000	8 696 000
Financial Costs	6 464 000	4 475 000	1 176 000	5 761 000
Financial Balance	2 173 000	−342 000	2 639 000	2 935 000
Earnings Before Tax	−50 983 000	−11 117 000	180 904 000	−95 956 000
Tax	−8 240 000	−1 704 000	31 130 000	0
Net Income	−42 743 000	−9 413 000	149 774 000	−95 956 000

Balance (USD)	2022	2021	2020	2019
Total Fixed Assets	9 604 000	9 698 000	996 000	976 000
Total Current Assets	211 873 000	255 858 000	229 032 000	291 277 000
Total Assets	221 477 000	265 556 000	230 028 000	292 254 000
Total Retained Equity	73 362 000	104 333 000	113 756 000	−246 082 000
Total Equity	157 018 000	194 055 000	178 850 000	268 439 000
Total Long-Term Debt	25 474 000	40 135 000	37 997 000	0
Total Current Debt	38 985 000	31 367 000	13 181 000	23 815 000
Total Equity and Debt	221 477 000	265 557 000	230 028 000	292 254 000

Cash flow (USD)	2022	2021	2020	2019
Sales Income	7 168 000	33 963 000	215 000 000	489 000
Other Income	1 861 000	1 803 000	695 000	11 957 000
Revenue	9 029 000	35 766 000	215 695 000	12 446 000
Cost of Goods Sold	0	0	0	0
Salary Costs	18 047 000	16 846 000	16 049 000	29 355 000
Depreciation	1 813 000	735 000	303 000	136 000
Impairment	0	0	0	0
Expenditure	62 185 000	46 541 000	37 430 000	111 338 000
Operating Profit	−53 156 000	−10 775 000	178 265 000	−98 892 000
Financial Income	8 637 000	4 133 000	3 815 000	8 696 000
Financial Costs	6 464 000	4 475 000	1 176 000	5 761 000
Financial Balance	2 173 000	−342 000	2 639 000	2 935 000
Dividends	0	0	0	0
Net Income	−42 743 000	−9 413 000	149 774 000	−95 956 000

Balance details (USD)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	78 000	32 000	309 000	300 000
Real Eastate	9 526 000	7 281 000	131 000	0
Machinery and Plant Facilities	0	1 884 000	0	519 000
Fixtures	0	501 000	0	122 000
Total Tangible Assets	9 526 000	9 666 000	131 000	641 000
Total Fiancial Fixed Assets	0	0	556 000	36 000
Total Fixed Assets	9 604 000	9 698 000	996 000	976 000
Stock	0	0	0	0
Total Investments	0	12 169 000	39 943 000	190 369 000
Cash, Bank	206 386 000	216 231 000	183 851 000	89 256 000
Total Current Assets	211 873 000	255 858 000	229 032 000	291 277 000
Total Assets	221 477 000	265 556 000	230 028 000	292 254 000
Total Equity	157 018 000	194 055 000	178 850 000	268 439 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	25 474 000	40 135 000	37 997 000	0
Creditors	10 175 000	0	9 183 000	13 362 000
Unpaid Taxes	0	0	0	1 559 000
Dividends	0	0	0	0
Other Current Debt	28 730 000	31 341 000	3 998 000	8 894 000
Total Current Debt	38 985 000	31 367 000	13 181 000	23 815 000
Total Equity and Debt	221 477 000	265 557 000	230 028 000	292 254 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−27,22 %	−4,85 %	83,74 %	−35,75 %
Debt-to-Equity Ratio	0,16	0,21	0,21	0
Operating Profit Margin	−588,73 %	−30,13 %	82,65 %	−794,57 %
Current Ratio	5,43	8,16	17,38	12,23
Quick Ratio	5,43	8,16	17,38	12,23
Equity Ratio	0,71	0,73	0,78	0,92
Gross Profit Margin	100 %	100 %	100 %	100 %